Translate
Eledon Pharmaceuticals Inc
About
Eledon Pharmaceuticals Inc (NASDAQ:ELDN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 19 2026
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
Mar 16 2026
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Mar 10 2026
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
Mar 9 2026
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
Mar 4 2026
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
Recent Videos
NewCelX + Eledon Collab Update
Apr 21, 2026
Two pharma companies curing type 1 diabetes but one drug limits the cells its supposed to protect
Apr 18, 2026
Eledon update with Katie!
Apr 17, 2026
Base to Base biotech podcast 55: Beating transplant challenges and a circular supply chain
Apr 17, 2026